Maine has had a robust medical cannabis program for sometime. However, there was a significant reduction in the number of registered caregivers and assistants in 2022, despite an increase in patients.
In Maine's second full year in permitting Adult Use cannabis retail sales, cannabis retail sales increased roughly 94% from the year before. However, prices have fallen faster than in other states, which could have a negative impact on the program and Maine's cannabis businesses in the future.
On January 3, 2023, the Office of Cannabis Policy ("OCP") published a report, titled "State of Maine, Metrc User Group." The Report outlines various issues discussed by the working group and suggested resolutions.
The Office of Cannabis Policy has abandoned Maine's Residency Requirement for Maine's Medical Cannabis Program
The Office of Cannabis Policy confirms that it will no longer enforce Maine's residency requirement in the medical cannabis program.
Maine's Medical Cannabis Residency Requirement Rejected by the U.S. Court of Appeals for the First Circuit
The U.S. Court of Appeals for the First Circuit affirmed a lower courts decision that the Dormant Commerce Clause applies to the cannabis industry; as such, Maine's Residency Requirement for its Medical Cannabis Program violates the Commerce Clause of the U.S Constitution.
Maine Office of Cannabis Policy Cannabis Markets & Associated Outcomes - Survey Findings and Implications
Maine Office of Cannabis Policy Cannabis Markets & Associated Outcomes - Survey Findings and Implication. Data suggests that Adult Use stores may help reduce the illicit cannabis marketplace.